Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock enjoyed a major increase of 12.4% on 12/21/23. The shares closed at $16.07. Moreover, trading volume in this advance was unusually high at 194% of normal. The stock has performed in line with the market over the last nine months and has risen 14.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, CPRX is expected to continue to be a major Value Builder.
Catalyst Pharmaceutical has a current Value Trend Rating of B (Positive). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Catalyst Pharmaceutical has a very high Appreciation Score of 97 but a neutral Power Rating of 43, triggering the Positive Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment